Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104567173 | 10456717 | 3 | F | 20160811 | 20140916 | 20160817 | PER | US-PFIZER INC-2014252406 | PFIZER | 65.00 | YR | M | Y | 0.00000 | 20160817 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104567173 | 10456717 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, 2X/DAY | U | 21446 | 75 | MG | CAPSULE, HARD | BID | |||||
| 104567173 | 10456717 | 2 | C | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | 50 MG, AS NEEDED (TABLET Q 4 H PRN) | 0 | 50 | MG | TABLET | ||||||||
| 104567173 | 10456717 | 3 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 10-325 MG (TWO TIMES DAILY AS NEEDED) | 0 | 1 | DF | TABLET | ||||||||
| 104567173 | 10456717 | 4 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | 2 DF, DAILY (50MCG/ACT 2PUFF DAILY)) | 0 | 2 | DF | |||||||||
| 104567173 | 10456717 | 5 | C | CLONIDINE HCL | CLONIDINE HYDROCHLORIDE | 1 | 0.2 MG, 2X/DAY | 0 | .2 | MG | TABLET | BID | |||||||
| 104567173 | 10456717 | 6 | C | METFORMIN HCL | METFORMIN HYDROCHLORIDE | 1 | 500 MG, 2X/DAY | 0 | 500 | MG | TABLET | BID | |||||||
| 104567173 | 10456717 | 7 | C | LABETALOL HCL | LABETALOL HYDROCHLORIDE | 1 | 200 MG, 2X/DAY (EVERY TWELEVE HOURS) | 0 | 200 | MG | TABLET | BID | |||||||
| 104567173 | 10456717 | 8 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 50 MG, DAILY | 0 | 50 | MG | TABLET | ||||||||
| 104567173 | 10456717 | 9 | C | LEVEMIR | INSULIN DETEMIR | 1 | 30 IU, (AT BEDTIME) | 0 | 30 | IU | QD | ||||||||
| 104567173 | 10456717 | 10 | C | METANX | LEVOMEFOLATE CALCIUMMETHYLCOBALAMINPYRIDOXAL PHOSPHATE ANHYDROUS | 1 | (3-90.314-2-35 MG) 1 CAPSULE TWO TIMES DAILY | 0 | 1 | DF | CAPSULE | BID | |||||||
| 104567173 | 10456717 | 11 | C | FISH OIL | FISH OIL | 1 | Oral | 1200 MG, 2X/DAY | 0 | 1200 | MG | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104567173 | 10456717 | 1 | Diabetes mellitus |
| 104567173 | 10456717 | 2 | Pain |
| 104567173 | 10456717 | 3 | Lumbar spinal stenosis |
| 104567173 | 10456717 | 4 | Eustachian tube dysfunction |
| 104567173 | 10456717 | 5 | Accelerated hypertension |
| 104567173 | 10456717 | 6 | Diabetes mellitus |
| 104567173 | 10456717 | 7 | Accelerated hypertension |
| 104567173 | 10456717 | 8 | Accelerated hypertension |
| 104567173 | 10456717 | 9 | Diabetes mellitus |
| 104567173 | 10456717 | 10 | Diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104567173 | 10456717 | Disease recurrence | |
| 104567173 | 10456717 | Pain | |
| 104567173 | 10456717 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |